Status:

COMPLETED

Clinical Evaluation of Reusable Soft Contact Lenses

Lead Sponsor:

CooperVision International Limited (CVIL)

Conditions:

Myopia

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study was to confirm the clinical performance of a novel manufacturing process for comfilcon A contact lenses in habitual wearers over a one-month period of lens wear.

Detailed Description

This was a prospective, multiple day, double-masked (investigator and subject), randomized, bilateral re-fit parallel arm study comparing a Test Lens against an appropriate Control Lens. Participants ...

Eligibility Criteria

Inclusion

  • Have had a self-reported oculo-visual examination in the last year.
  • Are at least 18 years of age and has full legal capacity to give their informed consent.
  • Have read and understood the informed consent letter.
  • Are willing and able to follow instructions and maintain the appointment schedule.
  • Have a contact lens spherical prescription between -0.50 D to -6.00 D (inclusive)
  • Are correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best-corrected.
  • Have spectacle cylinder of ≤ 0.75 D in both eyes.
  • Is a habitual comfilcon A wearer and worn a comfilcon A lens for at least one month (minimum of 8 hours a day, 5 days per week)
  • Currently employ the use of a peroxide or multipurpose solution cleaning and disinfecting regimen in one of the following brand names:
  • Bausch and Lomb BioTrue Multi-Purpose Solution
  • Bausch and Lomb BioTrue Hydration Plus Multi-Purpose Solution
  • Bausch and Lomb ReNu Advanced Formulation Multi-Purpose Solution
  • Alcon Opti-Free Puremoist with Hydraglyde Multi-Purpose Solution
  • Alcon Opti-Free Replenish Multi-Purpose Solution
  • Alcon Clear Care Plus Hydrogen Peroxide Solution
  • Acuvue RevitaLens Multi-Purpose Solution
  • Have clear corneas and no active ocular disease.
  • Have not worn habitual lenses for at least 12 hours before the baseline/screening examination
  • Are willing to wear the study contact lenses for at least 8 hours per day, 5 days per week

Exclusion

  • Have never worn contact lenses before.
  • Are currently wearing daily disposable contact lenses.
  • Have any systemic disease affecting ocular health.
  • Are using any systemic or topical medications that will affect ocular health.
  • Have any ocular pathology or abnormality that would affect the wearing of contact lenses.
  • Have any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Are aphakic.
  • Have undergone corneal refractive surgery.
  • Are participating in any other type of eye related clinical or research study.
  • Require a change in lens power from more than 1 diopter as dictated by over-refraction with their habitual lens prescription.

Key Trial Info

Start Date :

November 14 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2024

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT06119191

Start Date

November 14 2023

End Date

March 1 2024

Last Update

April 8 2025

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Clinical Research Center, UC Berkeley

Berkeley, California, United States, 94720

2

Clinical Optics Research Lab at IU School of Optometry

Bloomington, Indiana, United States, 47405

3

SUNY College of Optometry Clinical Vision Research Center

New York, New York, United States, 10016

4

Ohio State University College of Optometry

Columbus, Ohio, United States, 43210